A retrospective study to assess clinical outcomes of rVIII-SingleChain and other commonly used recombinant FVIII (rFVIII) products in real-world settings
Latest Information Update: 01 Jan 2021
At a glance
- Drugs Efmoroctocog alfa (Primary) ; Lonoctocog alfa (Primary) ; Moroctocog alfa (Primary) ; Octocog alfa (Primary) ; Octocog alfa (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- 01 Jan 2021 New trial record